Pallando Therapeutics
PrivateLast Round
Seed
Jun 24, 2025
Total Funding Raised
$8M
Company Overview
Pallando Therapeutics operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Seed round in June 2025.
Pallando Therapeutics is a biotechnology company that provides precision targeting services intended to transform the oncology treatment landscape.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pallando Therapeutics Comparables
Compare Pallando Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TenSixty Bio | 85% | |
| Entact Bio | 81% | |
| Vicinitas Therapeutics | 80% |
For institutional investors. Book with your work email.
Pallando Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Pallando Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Seed |
| General Catalyst | Seed |
| BVF Partners L.P. | Seed |
| Astellas Venture Management | Seed |
| 8VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2025
Raised $8M with participation from General Catalyst and 8VC.
For institutional investors. Book with your work email.
Pallando Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pallando Therapeutics's valuation, stock price, and market status.
Is Pallando Therapeutics a public or private company?
Pallando Therapeutics is a private company.
What is the current stock price of Pallando Therapeutics?
Pallando Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pallando Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pallando Therapeutics worth (valuation)?
Valuation information for Pallando Therapeutics is not publicly available.
Can I buy Pallando Therapeutics stock?
Pallando Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pallando Therapeutics's last funding round?
Pallando Therapeutics's most recent funding round was Seed on June 24, 2025.
Who are the main investors in Pallando Therapeutics?
Key investors in Pallando Therapeutics include Gaingels, General Catalyst, BVF Partners L.P., Astellas Venture Management, 8VC.
Will Pallando Therapeutics IPO soon?
No public IPO plans have been announced for Pallando Therapeutics.
How can I track Pallando Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pallando Therapeutics's shares on secondary markets.